SNSS Financial Facts
Loss from operations: -9.99MResearch and development: 6.61M
See Full Income Statement
Total current assets: 33.95M
Prepaids and other current assets: 831K
See Full Balance Sheet
Sunesis Pharmaceuticals Inc. (SNSS) Earnings
|
Expand Research on SNSS
Next EPS Date | N/A | EPS Growth Rate | N/A |
---|---|---|---|
Average EPS % Beat Rate | +18.6% | Revenue Growth Rate | N/A |
Average % Move 1-Wk after EPS | -39.1% | Normal Earnings Time | N/A |
Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
---|---|---|---|---|---|---|---|---|---|---|---|
11/8/12 | Q312 | -$0.37 | -$0.13 | -$0.24 | $265K | $4.17M | N/A | Details | |||
3/29/11 | Q410 | -$0.23 | -$0.10 | -$0.13 | N/A | N/A | N/A | Details | |||
5/15/12 | Q112 | -$0.30 | -$0.18 | -$0.12 | N/A | $90K | N/A | Details | |||
5/7/14 | Q114 | -$0.26 | -$0.17 | -$0.09 | $2M | $1.32M | N/A | Details | |||
11/10/14 | Q314 | -$0.25 | -$0.17 | -$0.08 | $854K | $1.97M | N/A | Details | |||
8/11/11 | Q211 | -$0.18 | -$0.15 | -$0.03 | N/A | $10K | N/A | Details | |||
5/9/13 | Q113 | -$0.23 | -$0.20 | -$0.03 | $1.99M | $750K | N/A | Details | |||
8/5/14 | Q214 | -$0.20 | -$0.17 | -$0.03 | $2M | $1.32M | N/A | Details |